PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35592411-12 2022 Supporting the central involvement of the cAMP/PKA/LKB1/AMPKalpha2 signaling pathway in the cardioprotective effects of LQ, inhibition of Ang II-induced hypertrophy and induction of LKB1 and AMPKalpha phosphorylation were no longer observed after inhibiting PKA activity. liquiritin 120-122 angiotensinogen Rattus norvegicus 138-144 35592411-13 2022 Conclusion: This study revealed that LQ alleviates pressure overload-induced cardiac hypertrophy in vivo and inhibits Ang II-induced cardiomyocyte hypertrophy in vitro via activating cAMP/PKA/LKB1/AMPKalpha2 signaling. liquiritin 37-39 angiotensinogen Rattus norvegicus 118-124 35341136-0 2022 Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway. liquiritin 0-10 angiotensinogen Rattus norvegicus 22-36 35341136-1 2022 Objective: To investigate the protective effect and mechanism of liquiritin (LIQ) on cardiomyocyte hypertrophy induced by angiotensin II (Ang II). liquiritin 65-75 angiotensinogen Rattus norvegicus 122-136 35341136-1 2022 Objective: To investigate the protective effect and mechanism of liquiritin (LIQ) on cardiomyocyte hypertrophy induced by angiotensin II (Ang II). liquiritin 65-75 angiotensinogen Rattus norvegicus 138-144 35341136-1 2022 Objective: To investigate the protective effect and mechanism of liquiritin (LIQ) on cardiomyocyte hypertrophy induced by angiotensin II (Ang II). liquiritin 77-80 angiotensinogen Rattus norvegicus 122-136 35341136-8 2022 The protective effect of LIQ was best observed at 30 muM after Ang II treatment. liquiritin 25-28 angiotensinogen Rattus norvegicus 63-69 35341136-10 2022 On the other hand, Western blotting results showed that Ang II increased the ATE1 protein levels and TAK1 and JNK1/2 phosphorylation, which were significantly alleviated after LIQ treatment. liquiritin 176-179 angiotensinogen Rattus norvegicus 56-62 35341136-12 2022 Conclusion: LIQ can attenuate Ang II-induced cardiomyocyte hypertrophy by regulating the ATE1/TAK1-JNK1/2 pathway. liquiritin 12-15 angiotensinogen Rattus norvegicus 30-36